[ad_1]
As accessibility to the abortion tablet mifepristone hangs in authorized limbo, former Fda Commissioner Jane Henney reflects on the agency’s choice to approve the drug in 2000.
[ad_2]
Source backlink
[ad_1]
As accessibility to the abortion tablet mifepristone hangs in authorized limbo, former Fda Commissioner Jane Henney reflects on the agency’s choice to approve the drug in 2000.
[ad_2]
Source backlink